FDA Approves Cimduo (lamivudine and tenofovir disoproxil fumarate) Tablets for the Treatment of HIV Infection
Company: Mylam Pharmaceutical Inc.
Generic Name: lamivudine and tenofovir disoproxil fumarate
Dosage Form: Tablets
Treatment for: HIV Infection
General information about Cimduo
The U.S. Food and Drug Administration (FDA) has approved Cimduo (lamivudine and tenofovir disoproxil fumarate), a combination of two nucleo(t)side reverse transcriptase inhibitors indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.
Cimduo is a prescription medicine that is used with other antiretroviral medicines to treat Human Immunodeficiency Virus-1 (HIV-1) in adults and children weighing at least 35 kg.
HIV-1 is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).
Cimduo contains the prescription medicines lamivudine and tenofovir disoproxil fumarate.